| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/28/2005 | WO2005068626A1 Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent |
| 07/28/2005 | WO2005068624A1 Method of screening remedy for rheumatoid arthritis |
| 07/28/2005 | WO2005068618A1 Polynucleotides encoding novel ubch10 polypeptides and kits and methods using same |
| 07/28/2005 | WO2005068611A1 Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans |
| 07/28/2005 | WO2005068504A1 Inflammatory cytokine inhibitor |
| 07/28/2005 | WO2005067971A1 Drug for preventing and treating arteriosclerosis |
| 07/28/2005 | WO2005067912A1 Method of intentionally, noninvasively, therapeutically modulating fat in a living mammal |
| 07/28/2005 | WO2005067692A2 Detection and quantification of analytes in solution using polymers |
| 07/28/2005 | WO2005067667A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 07/28/2005 | WO2005067650A2 Gene expression profiles and methods of use |
| 07/28/2005 | WO2005067648A2 Multiplex spatial profiling of gene expression |
| 07/28/2005 | WO2005067646A2 Primers and probes for the detection of hiv |
| 07/28/2005 | WO2005067643A2 Determination of hepatitis c virus genotype |
| 07/28/2005 | WO2005067640A2 Methods for enhanced detection & analysis of differentially expressed genes using gene chip microarrays |
| 07/28/2005 | WO2005067629A2 Cancer-linked genes as targets for chemotherapy |
| 07/28/2005 | WO2005067603A2 Autism-associated polymorphisms and uses thereof |
| 07/28/2005 | WO2005067583A2 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 07/28/2005 | WO2005067580A2 Naphthofluorescein-based metal sensors, and methods of making and using the same |
| 07/28/2005 | WO2005067486A2 Quantitative protein assay using single affinity capture agent for identification and detection |
| 07/28/2005 | WO2005067425A2 Bacterial biosensors |
| 07/28/2005 | WO2005067405A2 Method for screening responsiveness to drugs effective in treatment or prevention of vitiligo and method for prognosis of vitiligo |
| 07/28/2005 | WO2005067391A2 Diagnostic test for parkinson's disease |
| 07/28/2005 | WO2005061709A3 Variable valve apparatus and methods |
| 07/28/2005 | WO2005054510A3 Predicting response and outcome of metastatic breast cancer anti-estrogen therapy |
| 07/28/2005 | WO2005054438A3 Nucleic acid molecules containing recombination sites and methods of using the same |
| 07/28/2005 | WO2005051970A3 Highly parallel dna synthesiser based on matrices |
| 07/28/2005 | WO2005047901A3 Compositions and methods for detection and isolation phosphorylated molecules |
| 07/28/2005 | WO2005047530A3 Method for assaying compounds that modulate the activity of protein tyrosine phosphatase receptor zeta (ptprzeta) |
| 07/28/2005 | WO2005045062A3 Gene expression and polymorphisms associated with lung cancer |
| 07/28/2005 | WO2005041880A3 RhPV AS A MODEL FOR HPV-INDUCED CANCERS |
| 07/28/2005 | WO2005040425A3 Nucleic acid sequencing methods |
| 07/28/2005 | WO2005040396A3 qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING |
| 07/28/2005 | WO2005035545A3 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 07/28/2005 | WO2005033330A3 Fluorescent probes for use in protein kinase inhibitor binding assay |
| 07/28/2005 | WO2005033309A3 Plant promoters and methods of use thereof |
| 07/28/2005 | WO2005031341A3 Methods for predicting development of insulin resistance |
| 07/28/2005 | WO2005027710A3 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 07/28/2005 | WO2005020890A3 Multiplexed molecular beacon assay for detection of pathogens |
| 07/28/2005 | WO2005017102A3 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 07/28/2005 | WO2005016279A3 Melks as modifiers of the rac pathway and methods of use |
| 07/28/2005 | WO2005013682A3 Animal model for the analysis of tumor metastasis |
| 07/28/2005 | WO2005012901A3 Method for measuring aromatase activity |
| 07/28/2005 | WO2005009366A3 Restoring vascular function |
| 07/28/2005 | WO2005003394A3 Bio-barcode based detection of target analytes |
| 07/28/2005 | WO2005003289A3 Ap1 amine oxidase variants |
| 07/28/2005 | WO2005001111A3 Primers and probes for amplification and detection of human inhibitor of dna-binding |
| 07/28/2005 | WO2004111268A3 Mutations in the slc40a1 gene associated to impaired iron homeostasis |
| 07/28/2005 | WO2004096991A3 Bcl2l12 polypeptide activators and inhibitors |
| 07/28/2005 | WO2004087957A3 Hypermethylated genes and cervical cancer |
| 07/28/2005 | WO2004070032A8 Method of preparing template dna to be used in polymerase chain reaction from microbial cells |
| 07/28/2005 | WO2004069189A3 Methods of assessment of drug metabolizing enzymes |
| 07/28/2005 | WO2004043236A3 Diagnosis of sepsis or sirs using biomarker profiles |
| 07/28/2005 | WO2004037977A3 Use of chimeric nucleases to stimulate gene targeting |
| 07/28/2005 | WO2004035806A3 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 07/28/2005 | WO2004021248A3 Automated framework for the analysis of biological data |
| 07/28/2005 | WO2004015076A3 Novel proteins and nucleic acids encoding same |
| 07/28/2005 | WO2004003820A3 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 07/28/2005 | WO2004002296A3 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 07/28/2005 | WO2003103597A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 07/28/2005 | WO2003094088A8 Mouse olfactory receptor gene superfamily specification |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2003063693A3 Method for detecting microorganisms |
| 07/28/2005 | WO2003027249A3 High-protein-phenotype-associated plant genes |
| 07/28/2005 | WO2002080758A3 Methods for treating drug addiction |
| 07/28/2005 | US20050166282 Method and polynucleotides for determining translational efficiency of a codon |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050166269 Sleep genes in Drosophila and their use for the screening, diagnosis and therapy of sleep disorders |
| 07/28/2005 | US20050165224 Inhibition of penicillin resistance in s. pneumoniae |
| 07/28/2005 | US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/28/2005 | US20050165115 serotonin transporter gene-linked polymorphic region (5HTTLPR) is genotyped; Based on the identified genotype, a particular antidepressant treatment regimen suitable for the patient is determined; kits |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050164974 Ligand is covalently linked to polyoxyethylene glycol having specific binding affinity for vascular endothelial growth factor; SELEX method; improved pharmacokinetics |
| 07/28/2005 | US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 07/28/2005 | US20050164964 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164911 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 07/28/2005 | US20050164907 Comparing level or bioactivity of Wnt protein/PCP pathway component, frizzled related protein gene product of the Wnt/PCP pathway, or FRP of the Wnt/PCP pathway with the level in a normal sample |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164411 Using solid support comprising immobilized monoclonal antibodies to identify blood pathogen and/or toxins; high throughput assay |
| 07/28/2005 | US20050164410 Device which utilizes electrochemiluminescence at electrode surface to monitor binding of preferential particles; high throughput assay |
| 07/28/2005 | US20050164407 Increasing the sensitivity and specificity of nucleic acid chip hybridization tests |
| 07/28/2005 | US20050164393 Method for identifying genes encoding signal sequences |
| 07/28/2005 | US20050164382 Differentiation protocol for making human cardiomyocytes |
| 07/28/2005 | US20050164376 Multicompartment bioreactor for propagation and lysis of preferential cells |
| 07/28/2005 | US20050164353 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 07/28/2005 | US20050164342 Cloned glutamic acid decarboxylase |
| 07/28/2005 | US20050164336 Extraction; chromatography; mass spectrometry |
| 07/28/2005 | US20050164333 Method and apparatus for detecting phycocyanin-pigmented algae and bacteria from reflected light |
| 07/28/2005 | US20050164332 Method and apparatus for detecting coliform bacteria from reflected light |
| 07/28/2005 | US20050164331 Method and device for detecting toxic material in water using microbial fuel cell |
| 07/28/2005 | US20050164330 Using reagent comprising enzyme, nad/nadh and nadp/nadph to measure concentration of preferential compound in blood, plasma, serum and/or urine; reduced interference by hemoglobin; colorimetric analysis |
| 07/28/2005 | US20050164329 Analyte measurement |
| 07/28/2005 | US20050164328 Substrate determining method |
| 07/28/2005 | US20050164325 Method of mass spectrometry |
| 07/28/2005 | US20050164324 Systems, methods and kits for characterizing phosphoproteomes |
| 07/28/2005 | US20050164323 Identifying modulators of protein kinase c for use as treatments of respiratory system disorders; antiasthmatic agents |
| 07/28/2005 | US20050164322 Non-leachable or diffusible redox mediator; for glucose or lactate concentrations |
| 07/28/2005 | US20050164321 Luminogenic and nonluminogenic multiplex assay |
| 07/28/2005 | US20050164318 Using presence of skeletal troponin as evaluative indicator of muscle injury; detecting hypoxic and/or ischemic events; antihypoxic agents; antiischemic agents |
| 07/28/2005 | US20050164316 Biophotonic sensors and methods of use thereof |